The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis

Immunotherapy is a novel treatment for advanced non-small cell lung cancer (NSCLC) patients. Immunotherapy includes two main broad classes of therapeutic vaccines and immune checkpoint inhibitors, as well as cytokines, biological response modifiers and cellular therapy. The present systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Liang, Wang, Xi-Ling, Deng, Qing-Long, Du, Yan-Qiu, Zhao, Nai-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997317/
https://www.ncbi.nlm.nih.gov/pubmed/27558285
http://dx.doi.org/10.1038/srep32020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997317/
https://www.ncbi.nlm.nih.gov/pubmed/27558285
http://dx.doi.org/10.1038/srep32020

Ejemplares similares